Eyfem Eye Drop Forte 5ml
₨ 250
About this product
Overview
Product Overview
Eyfem Eye Drop Forte 5Ml is an eye drop combining an antibiotic and a steroid, containing Fluorometholone & Neomycin. It is available as an eye preparation for convenient use.
Uses of
Eyfem Eye Drop Forte 5Ml
Eyfem Eye Drop Forte 5Ml is prescribed for treating eye inflammation with, or at risk of, bacterial infection. Use it only as advised by your doctor.
Key Benefits
Used correctly, it reduces eye inflammation while treating or preventing infection.
Active Ingredients
The active ingredient is Fluorometholone & Neomycin. It combines an antibiotic with an anti-inflammatory steroid.
Recommended Dosage
Take exactly the dose your doctor prescribes. Do not change or stop it without medical advice.
Side Effects
Possible Side Effects include stinging, blurred vision or raised eye pressure with long use. Tell your doctor if any are severe or persistent.
Warnings and Precautions
Use only for the prescribed period; needs eye-pressure checks if used long. Also tell your doctor about your allergies and other medicines.
Storage Instructions
Store as directed, keep closed, and discard within four weeks of opening unless told otherwise.
This information is for general awareness only. It does not replace advice from your doctor or pharmacist. Always read the leaflet and follow the directions you were given.
Substitutes for Eyfem Eye Drop Forte 5ml
These medicines contain the same salt as Eyfem Eye Drop Forte 5ml (Fluorometholone & Neomycin 5ml), so they are common substitutes. Compare their prices, and change brands only after checking with your doctor or pharmacist.
| Medicine | Manufacturer | Pack | Price |
|---|---|---|---|
| Eyfem-N Eye Drop 5ml | Kobec Pharmaceuticals | - | Rs 77 |
| FML-NEO Eye Drop 5ml | Barrett Hodgson | 1 | Rs 119 |
| Florom-N Eye Drop 5ml | Schazoo Laboratories | - | Rs 126 |
| Eyfem Eye Drop 5ml | Kobec Pharmaceuticals | - | Rs 145 |
Customer reviews
You must be logged in to post a review.
Reviews
Clear filtersThere are no reviews yet.